Loading
A phase 2/3 trial of fOLFIRINOX / mFOLFIRINOX and fOLFOX (5-FU, leucovorin, oxaliplatin) in colorectal cancer, run by Chungnam National University Hospital, now recruiting.
Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer is a phase 2/3, randomised interventional study registered as NCT05179889 by Chungnam National University Hospital, with a registry enrolment figure of 308 participants, started 2021-07-06 and due to reach its primary completion in 2028-07-05. Interventions recorded: mFOLFIRINOX; mFOLFOX 6. Conditions listed: Colon Cancer Stage III. Primary outcome: Disease free survival (DFS). Colorectal eligibility wording from the registry: "Pathologically confirmed high-risk stage III colon adenocarcinoma (pT4N1 or pTanyN2)". Sites: South Korea. No results are recorded here; the registry entry is the source.
Shares FOLFIRINOX / mFOLFIRINOX, FOLFOX (5-FU, leucovorin, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.